In congruence with similar studies [18,19,40,49], our investigation into the utility of granzyme B tracking with GZP-PET revealed that it is a useful, real-time molecular imaging approach for imaging the adaptive immune response and evaluating individual tumor response to treatment. Here, GZMB is linked to neoplasm.